| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.8 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.8 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |